Abeomics

Abeomics is a dynamic platform that offers a wide range of scientific tools and resources to empower researchers and professionals in the life sciences field. Here are some key highlights:

• Recombinant Biosimilar Antibodies: Abeomics provides a selection of recombinant biosimilar antibodies, including Trastuzumab, Efalizumab, Mogamulizumab, and more. These antibodies play a crucial role in research, diagnostics, and therapeutic development.

• Monoclonal Antibodies and ELISA Kits: Explore their extensive collection of monoclonal antibodies, ELISA kits, and other assay tools. These high-quality reagents enable precise detection and quantification of specific targets.

• Reporter Cell Lines and Proteins: Abeomics offers stable cell lines expressing key proteins such as Caspase-3, DNMT1, B7-H4, and PD-L1. These reporter cell lines facilitate functional studies and drug screening.